Patents by Inventor Princy KHURANA

Princy KHURANA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-AMINO-S6-SUBSTITUTED THIOPURINE COMPOUNDS AS INHIBITORS OF THE ENPP1 PROTEIN
    Publication number: 20230002387
    Abstract: Compounds, pharmaceutical compositions, and methods are provided herein that may be used to treat cancer, infectious disease, and other conditions associated with ectonucleotide pyrophosphatase pyrophosphatase-phosphodiesterase (ENPP1) dysfunction.
    Type: Application
    Filed: September 15, 2020
    Publication date: January 5, 2023
    Applicants: ATEN PORUS LIFESCIENCES PVT. LTD., AVAMMUNE THERAPEUTICS INC
    Inventors: Aditya KULKARNI, Sandeep GOYAL, Princy KHURANA, Ketul PATEL, Rajath CYRIAC, Bala ANOOP SIRISH KATARU, Mukesh GANGAR, Apurba MUKHERJEE
  • Cyclodextrin based polymers, methods, compositions and applications thereof
    Patent number: 11447577
    Abstract: The present disclosure relates to polymers comprising conjugates of cyclodextrin or derivatives thereof and a linker moiety, methods of preparing the same and their application in the removal of lipids such as cholesterol from cells in treating lipid storage disorders. The present polymers exhibit improved properties including but not limiting to improved biocompatibility, improved retention time, prolonged duration of action in cells, and increased efficacy in removal of cholesterol from cells in treating lipid storage disorders.
    Type: Grant
    Filed: January 20, 2017
    Date of Patent: September 20, 2022
    Assignee: Aten Porus Lifesciences
    Inventors: Aditya Kulkarni, Atul Dolas, Princy Khurana, Soniya Johny, Manu Manjunath
  • CYCLODEXTRIN BASED POLYMERS, METHODS, COMPOSITIONS AND APPLICATIONS THEREOF
    Publication number: 20210102006
    Abstract: The present disclosure relates to polymers comprising conjugates of cyclodextrin or derivatives thereof and a linker moiety, methods of preparing the same and their application in the removal of lipids such as cholesterol from cells in treating lipid storage disorders. The present polymers exhibit improved properties including but not limiting to improved biocompatibility, improved retention time, prolonged duration of action in cells, and increased efficacy in removal of cholesterol from cells in treating lipid storage disorders.
    Type: Application
    Filed: January 20, 2017
    Publication date: April 8, 2021
    Inventors: Aditya KULKARNI, Atul DOLAS, Princy KHURANA, Soniya JOHNY, Manu MANJUNATH
  • Cyclodextrin based polymers, methods, compositions and applications thereof
    Patent number: 10869884
    Abstract: The present disclosure relates to polymers comprising conjugates of cyclodextrin or derivatives thereof and a linker moiety, and their application in treating lipid storage disorders by the removal of lipids such as cholesterol from cells. The polymers having the following structure: Formula (I), wherein CD, L, and n are defined herein, exhibit improved properties including but not limited to improved biocompatibility, improved retention time, prolonged duration of action in cells, and increased efficacy in treating a variety of kidney diseases and associated conditions.
    Type: Grant
    Filed: September 18, 2017
    Date of Patent: December 22, 2020
    Assignee: ATEN PORUS LIFESCIENCES
    Inventors: Aditya Kulkarni, Atul Dolas, Soniya Johny, Princy Khurana, Sandeep Goyal
  • CYCLODEXTRIN BASED POLYMERS, METHODS, COMPOSITIONS AND APPLICATIONS THEREOF
    Publication number: 20190209605
    Abstract: The present disclosure relates to polymers comprising conjugates of cyclodextrin or derivatives thereof and a linker moiety, and their application in treating lipid storage disorders by the removal of lipids such as cholesterol from cells. The polymers having the following structure: Formula (I), wherein CD, L, and n are defined herein, exhibit improved properties including but not limited to improved biocompatibility, improved retention time, prolonged duration of action in cells, and increased efficacy in treating a variety of kidney diseases and associated conditions.
    Type: Application
    Filed: September 18, 2017
    Publication date: July 11, 2019
    Applicant: ATEN PORUS LIFESCIENCES
    Inventors: Aditya KULKARNI, Atul DOLAS, Soniya JOHNY, Princy KHURANA, Sandeep GOYAL